Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Is Behcet's disease a contraindication to breast conserving therapy?
Related Questions
How would you treat a patient with HER2 positive CNS only progression on fam-trastuzumab which had previously progressed on tucatinib/capecitabine/trastuzumab, and has failed both SRS and WBRT?
With the presentation of HypoG-01 phase III UNICANCER trial at ESMO 2024, should hypofractionated radiotherapy be the standard across the board for breast cancer?
When do you consider the addition of concurrent pembrolizumab to breast irradiation?
Is there a role for radiation therapy for florid LCIS managed with lumpectomy?
How do you choose between ALND and RNI in the setting of LYMPHA or S-Lympha surgery?
How would you manage a patient presenting with recurrent cT4 breast cancer?
When evaluating for PMRT in patients who did not receive neoadjuvant chemotherapy and are found to be pN0, do you utilize clinical T-staging, or pathologic T-staging?
What are your top takeaways from SABCS 2023?
Do you routinely perform mammograms for women that underwent nipple-sparing mastectomy with reconstruction after a breast cancer diagnosis?
Are there additional risks associated with PMRT for a patient with prior lympho-venous bypass surgery?
